2026 International Spring Forum
April 15, 2026 | 12:00 PM EST
- Home
- Clinical Resources Search
- PQI: Cabozantinib (Cabometyx®)
Cabozantinib (Cabometyx®)
About this PQI
The purpose of this PQI is to provide a concise and comprehensive resource for proper medication management of patients utilizing Cabozantinib. Utilizing this resource should assist to decrease medication toxicities, improve medication adherence, and improve overall patient outcomes.

How to Use a Positive Quality Intervention (PQI)
Essentially, it’s a tool to improve patient care by sharing best practices in oncology care. Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.
Find a PQIFind Similar Resources
All Resources
PQI
PQI
PQI
PQI
PQI: Talectrectinib (Ibtrozi) for the Management of ROS1+ Advanced NSCLC
Author: Stefanie Houseknecht, PharmD, BCOP
Last Updated: 08/31/2025
PQI: Zanidatamab-hrii (Ziihera) for the Management of Biliary Tract Cancer
Author: Shelbie Gibbs, PharmD, BCOP
Last Updated: 08/31/2025
PQI: Prophylaxis and Management of Skin Toxicities with Amivantamab (Rybrevant) and Lazertinib (Lazcluze) Treatment: The COCOON Protocol
Author: Sharon Zhong, PharmD, BCOP
Last Updated: 08/31/2025
PQI: Encorafenib (Braftovi®) and Binimetinib (Mektovi®) for the Management of NSCLC
Author: Aubrey Lasko, PharmD, BCOP
Last Updated: 08/31/2025
PQI in Action
PQI in Action
PQI in Action
PQI in Action
PQI in Action: Fruquintinib (Fruzaqla®)
Author: Florida Cancer Specialists & Research Institute | Atlanticare Cancer Care Institute
Last Updated: 08/31/2025
PQI in Action: Management of Tucatinib (Tukysa®) and Trastuzumab in HER2-Positive Metastatic Colorectal Cancer – 2
Author: Johns Hopkins, MD | The University of Texas MD Anderson Cancer Center, TX
Last Updated: 08/31/2025
PQI in Action: Proactive Symptom Management in Myelofibrosis
Author: Cancer Specialists of North Florida
Last Updated: 08/31/2025
PQI in Action: Sonidegib (Odomzo®) Patient Management
Author: UCLA Medical Center | The Ohio State University Cancer Comprehensive Cancer Center (The James) | WVU Medicine
Last Updated: 08/31/2025
PQI Podcast
PQI Podcast
PQI Podcast
PQI Podcast
S9 E1: Head & Neck Cancer Care: Clinical Progress & Compassionate Practice
Author: Ginger Blackmon, PharmD | Deborah Wong, MD, PhD
Last Updated: 08/31/2025
S8 Bonus Eps 2: Inside ASCO 2025
Author: Ginger Blackmon, PharmD | Kelly Brunk, PharmD, BCOP
Last Updated: 08/31/2025
S8 E15: Supporting Survivors at Work
Author: Ginger Blackmon, PharmD | Rebecca Nellis, MPP
Last Updated: 08/31/2025
S8 E14: Advancing Geriatric Oncology
Author: Ginger Blackmon, PharmD | William Dale, MD, PhD, FASCO
Last Updated: 08/31/2025
Treatment Support Kit
Treatment Support Kit
Treatment Support Kit
Treatment Support Kit
Treatment Support Kit: Elranatamab
Last Updated: 08/31/2025
Treatment Support Kit: Mirdametinib
Last Updated: 08/31/2025
Treatment Support Kit: Abemaciclib
Last Updated: 08/31/2025
Treatment Support Kit: Temozolomide
Last Updated: 08/31/2025
Video
Video
Video
Video
Video: Akynzeo® (Ready-to-Use Vial): A Step-by-Step Video Guide
Last Updated: 08/31/2025
Video: BRUKINSA® (Zanubrutinib) for Treatment of Relapsed or Refractory Marginal Zone Lymphoma
Author: Brad Kahl, MD
Last Updated: 08/31/2025
Video: Ibrutinib-Related Cardiac Toxicities: Management & Dose Modifications
Author: Jo Ellen Rodgers, PharmD, BCPS, BCCP
Last Updated: 08/31/2025
Video: Neratinib for Extended Adjuvent Treatment of Adult Patients with Early-Stage HER2-Positive Breast Cancer (MIP)
Author: Joyce O’Shaughnessy, MD
Last Updated: 08/31/2025
PQI
PQI
PQI
Treatment Support Kit
PQI: Sorafenib (Nexavar®) for the Treatment of Hepatocellular Carcinoma and Transition to Second-line Regorafenib (Stivarga®)
Author: Jeff Engle, PharmD, MS
Last Updated: 08/31/2025
PQI: Regorafenib (Stivarga®) in the Treatment of Hepatocellular Carcinoma
Author: Jody Agena, PharmD
Last Updated: 08/31/2025
PQI: Durvalumab (Imfinzi®) Therapy Overview
Author: Joshua Nubla, PharmD
Last Updated: 08/31/2025
Treatment Support Kit: Cabozantinib
Last Updated: 08/31/2025
PQI
PQI Podcast
Treatment Support Kit
Treatment Support Kit
PQI: Tivozanib (Fotivda®) for Relapsed or Refractory Advanced Renal Cell Carcinoma
Author: Pedro C. Barata, MD
Last Updated: 08/31/2025
S7 Ep 2: Insights on Navigating Kidney Cancer Care
Author: Ginger Blackmon, PharmD | Emily Wang, PharmD, BCOP | Julia Stevens, PharmD, BCOP
Last Updated: 08/31/2025
Treatment Support Kit: Tivozanib
Last Updated: 08/31/2025
Treatment Support Kit: Cabozantinib
Last Updated: 08/31/2025
PQI
PQI
Treatment Support Kit
PQI: Selpercatinib (Retevmo®) Management
Author: Joshua Nubla, PharmD
Last Updated: 08/31/2025
PQI: Selpercatinib (Retevmo®) Genomic Testing Management
Author: Joshua Nubla, PharmD
Last Updated: 08/31/2025
Treatment Support Kit: Cabozantinib
Last Updated: 08/31/2025
PQI
PQI Podcast
Treatment Support Kit
PQI
PQI: Talectrectinib (Ibtrozi) for the Management of ROS1+ Advanced NSCLC
Author: Stefanie Houseknecht, PharmD, BCOP
Last Updated: 08/31/2025
S9 E1: Head & Neck Cancer Care: Clinical Progress & Compassionate Practice
Author: Ginger Blackmon, PharmD | Deborah Wong, MD, PhD
Last Updated: 08/31/2025
Treatment Support Kit: Elranatamab
Last Updated: 08/31/2025
PQI: Zanidatamab-hrii (Ziihera) for the Management of Biliary Tract Cancer
Author: Shelbie Gibbs, PharmD, BCOP
Last Updated: 08/31/2025